Skip Ribbon Commands
Skip to main content
PHO Rounds: Microbiology - Reclaiming legacy drugs with antibiotic adjuvants
Wednesday, February 25, 2015 02:00 pm to 03:00 pm
Venue: Webinar only
Laboratory Testing and Sciences; Research and Collaboration
City: Toronto
Format: Webinar

‚ÄčNote: This is an open invitation, and may be forwarded to interested parties.

The global antibiotic resistance crisis is having a dramatic impact on our ability to treat disease and to facilitate many of the procedures we enjoy in modern medicine. The history of antibiotics in the 20th century has been one of the cycles of discovery followed by the development of resistance that have been addressed with new discoveries. In the 21st century, this cycle has been broken with resistance continuing to rise and antibiotic discovery failing to keep up. While we do require new antibiotics, another strategy is to preserve the drugs we have by combatting resistance. Combinations of legacy antibiotics and molecules that enhance their activities even in the face of resistance (antibiotic adjuvants) have the potential to extend the utility of our 20th century drugs. Several examples of this strategy will be presented demonstrating the feasibility of such an approach.

DISCLAIMER: The opinions expressed by speakers and moderators do not necessarily reflect the official policies or views of Public Health Ontario, nor does the mention of trade names, commercial practices, or organizations imply endorsement by Public Health Ontario.

Presenter: Dr. Gerry Wright

Dr. Gerry Wright is the director of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University (2007 to present). He is professor in the Department of Biochemistry and Biomedical Sciences and associate member of the Departments of Chemistry and Chemical Biology as well as Pathology and Molecular Medicine.
He received his bachelor of science in biochemistry in 1986 and his doctorate in chemistry in 1990 from the University of Waterloo working in the area of antifungal drugs. He followed this up with two years of postdoctoral research at Harvard Medical School in Boston where he worked on the molecular mechanism of resistance to the antibiotic vancomycin in enterococci. He joined the Department of Biochemistry at McMaster in 1993.

PLEASE NOTE: We regret that CME credits cannot be provided for this session.


Stay up-to-date on upcoming events and calls for abstracts by visiting our calendar.
If you have submissions, or questions or comments about the items above, send them to

Public Health Ontario is committed to complying with the Accessibility for Ontarians with Disabilities Act (AODA).
If you require accommodations to participate in this event, please contact 647-260-7100 or


Uncontrolled print copy. Valid only on day of Print: [date]
Page updated on [date/time] 2015-03-12 9:44 AM
© , Ontario Agency for Health Protection and Promotion